The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the effects of drug-coated balloons (DCBs) on the interventional market; economic conditions and cost-containment initiatives; and clinical efforts to optimize therapeutic interventions.
Critical Issues Covered in this Report:
• Quantitative factors including units, pricing, and product sales;
• The competitive landscape for these devices in international markets; and
• Procedure volumes as well as other key infrastructure and market metrics.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
